10-Q: U.S. Physical Therapy Reports Strong Q2 Growth

U.S. Physical Therapy, Inc. announced significant revenue and earnings growth for the second quarter and first half of 2025, driven by strategic acquisitions and increased patient visits.

Summary

• Net revenue for the three months ended June 30, 2025, increased by 18.0% to $197.3 million, up from $167.2 million in the prior year period.
• Net income attributable to USPH shareholders for Q2 2025 rose by 65.1% to $12.4 million, compared to $7.5 million in Q2 2024.
• Basic and diluted earnings per share (EPS) for Q2 2025 increased to $0.58 from $0.47 in Q2 2024.
• For the six months ended June 30, 2025, net revenue grew 18.0% to $381.1 million, and net income attributable to USPH shareholders increased 43.3% to $22.3 million.
• EPS for the six months ended June 30, 2025, was $1.38, up from $0.93 in the comparable prior year period.
• The company added 6 clinics and closed 4 in Q2 2025, bringing the total owned and/or managed clinics to 768 as of June 30, 2025, compared to 722 as of June 30, 2024.
• Total patient visits for Q2 2025 increased by 16.7% to 1,558,756, with average daily visits per clinic rising 6.9% to 32.7.
• Net rate per patient visit for Q2 2025 increased to $105.33 from $105.05 in Q2 2024, despite an approximate 2.9% Medicare rate reduction effective January 1, 2025.
• The Industrial Injury Prevention Services (IIP) segment saw revenue increase by 22.6% to $29.1 million in Q2 2025 and gross profit increase by 25.8% to $6.4 million.
• Cash and cash equivalents were $34.1 million as of June 30, 2025, with $150.5 million in available credit under Senior Credit Facilities.

Sentiment

Score: 8

Explanation: The company reported strong financial results with significant growth in revenue, net income, and EPS. Strategic acquisitions are successfully integrated, and key operating metrics like patient visits and net rate per visit are positive. The initiation of a share repurchase program further enhances shareholder value. While cash reserves decreased due to acquisitions and interest expenses rose, the company maintains ample liquidity and is actively managing its debt and interest rate exposure. The overall outlook is positive, reflecting effective management and a robust growth strategy.

Positives

• Strong revenue growth of 18.0% for both the three and six months ended June 30, 2025, indicating robust business expansion.
• Significant increase in net income attributable to USPH shareholders (65.1% for Q2, 43.3% for six months), demonstrating improved profitability.
• Earnings per share (EPS) showed substantial growth, increasing from $0.47 to $0.58 in Q2 and $0.93 to $1.38 for the six-month period.
• Continued expansion of clinic network with 51 net clinics added since the comparable prior year period, contributing to increased patient visits.
• Successful increase in net rate per patient visit to $105.33 in Q2 2025, despite a 2.9% Medicare rate reduction, reflecting effective contract negotiations and accretive acquisitions.
• Industrial Injury Prevention Services (IIP) segment demonstrated strong performance with 22.6% revenue growth and 25.8% gross profit growth in Q2 2025.
• The company maintains strong liquidity with $150.5 million in available credit under its Senior Credit Facilities as of June 30, 2025.
• A new share repurchase program of up to $25 million was approved, signaling management's confidence and commitment to shareholder returns.
• The interest rate swap agreement generated $1.0 million in interest savings for the six months ended June 30, 2025, mitigating rising interest expenses.

Negatives

• Cash and cash equivalents decreased to $34.1 million as of June 30, 2025, from $41.4 million at December 31, 2024, primarily due to funding acquisitions.
• Interest expense increased by $0.4 million in Q2 2025 and $0.8 million for the six months ended June 30, 2025, due to higher average outstanding debt balances and increased interest rates.
• Interest income from investments significantly decreased to less than $0.1 million in Q2 2025 from $1.1 million in Q2 2024, as cash was deployed for acquisitions.
• Corporate office costs increased by 22.6% in Q2 2025, primarily due to supporting a larger clinic network, acquisition integration, and new financial/HR system implementation costs.

Risks

• Changes in Medicare rules and guidelines and reimbursement, or failure to maintain Medicare certification/enrollment status.
• Potential retroactive reduction of revenue from Medicare and Medicaid.
• Changes in reimbursement rates or payment methods from third-party payors, including government agencies, and changes in patient deductibles and co-pays.
• Compliance with federal and state laws regarding patient information privacy (HIPAA) and corporate practice of medicine/fee splitting, with associated fines and penalties.
• Competitive, economic, or reimbursement conditions in markets that may necessitate clinic reorganization or closure, leading to losses or asset write-downs.
• Impact of future public health crises and epidemics/pandemics.
• Impact of future vaccination and/or testing mandates on staffing, revenue, and costs.
• Debt and financial obligations could adversely affect financial condition, ability to obtain future financing, and business operations.
• Changes resulting from government-enacted national healthcare reform.
• Challenges in controlling variable interest entities where direct ownership is not held.
• Governmental and other third-party payor inspections, reviews, investigations, and audits, potentially leading to sanctions, damages, or reputational harm.
• Contingent consideration provisions in acquisition agreements, the value of which may impact future financial results.
• Legal actions, including qui tam lawsuits under the False Claims Act, which could lead to increased operating costs and uninsured liabilities.
• General economic conditions, including inflationary and recessionary periods, and banking volatility or liquidity problems.
• Dependence on hiring, training, and retaining qualified employees, particularly physical therapists.
• Competitive environment in the industrial injury prevention services business, potentially leading to contract termination or non-renewal.
• Ability to identify and complete acquisitions, and successfully integrate acquired businesses.
• Impact on business and cash reserves from retirement or resignation of key partners and the resulting purchase of their non-controlling interests.
• Maintaining information technology systems with adequate safeguards against cyber-attacks and potential security breaches.
• Maintaining clients for management and industrial injury prevention services, as contract breaches or terminations could negatively impact operating results.
• Maintaining adequate internal controls and necessary insurance coverage.
• Availability, terms, and use of capital.
• Weather and other seasonal factors affecting operations.

Future Outlook

The company plans to continue its strategy of acquiring multi-clinic outpatient physical therapy practices and home-care physical and speech therapy practices, developing satellite clinics, and acquiring companies in the industrial injury prevention services sector. Management expects to continue implementing a new financial and human resources system through the end of 2026. The recently enacted 'One Big Beautiful Bill Act' is being evaluated for its impact on future tax periods, potentially allowing for more favorable deductibility of certain business expenses beginning in 2025. A share repurchase program of up to $25 million has been approved, effective August 5, 2025, through December 31, 2026, indicating a commitment to shareholder returns.

Management Comments

• Our strategy is to continue acquiring multi-clinic outpatient physical therapy practices and home-care physical and speech therapy practices, develop outpatient physical therapy clinics as satellites in existing partnerships, and continue acquiring companies that provide or serve our IIP sector.
• The increase in net rate per patient visit reflects the Company's strategic priority of increasing reimbursement rates through contract negotiations with commercial and other payors, and the addition of acquisitions with accretive net rate per patient visit.
• Implementation costs associated with the new financial and human resources system are expected to continue through the end of 2026.
• We believe that our cash and cash equivalents and availability under our Senior Credit Facilities are sufficient to fund the working capital needs of our operating subsidiaries through at least June 30, 2026.

Industry Context

The U.S. physical therapy and industrial injury prevention sectors continue to show growth, with U.S. Physical Therapy, Inc. actively participating in industry consolidation through strategic acquisitions. The company's ability to increase its net rate per patient visit despite Medicare rate reductions highlights its strong market position and effective payor negotiation strategies. The focus on both traditional physical therapy and the specialized IIP segment positions the company to capitalize on diverse healthcare and corporate wellness trends. The industry faces ongoing regulatory changes, particularly concerning Medicare reimbursement, and a competitive environment for qualified personnel, which the company addresses through its acquisition and operational strategies.

Comparison to Industry Standards

• The company's 18.0% net revenue growth significantly outpaces the average growth rates for many established healthcare service providers, indicating strong market penetration and successful acquisition integration.
• The increase in net rate per patient visit to $105.33, despite a 2.9% Medicare rate reduction, suggests superior contract negotiation and service value compared to peers who might struggle more with reimbursement pressures.
• The expansion to 768 owned/managed clinics demonstrates an aggressive growth strategy, comparable to leading consolidators in the fragmented physical therapy market, such as ATI Physical Therapy or Select Medical, though specific direct comparisons of growth rates would require their respective filings.
• The 6.9% increase in average daily visits per clinic to 32.7 indicates efficient utilization of existing clinic infrastructure and strong patient demand, a key operational efficiency metric for outpatient healthcare providers.

Management Changes

Corporate Governance

Legal Proceedings

• The company is a party to various legal actions, proceedings, claims, and regulatory/governmental audits in the ordinary course of business.
• Cannot predict the ultimate outcome of pending litigation, which could result in sanctions, damages, recoupments, fines, and other penalties.
• Healthcare providers are subject to lawsuits under the qui tam provisions of the federal False Claims Act, which can involve significant monetary damages and penalties.

Related Party Transactions

• Lease payments totaling $0.2 million were made to Michael G. Mayrsohn (President of Metro and Board Director) for the six months ended June 30, 2025.
• Minimum future rental payments under these related party lease agreements amount to $2.9 million as of June 30, 2025.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, increased EPS, and the initiation of a share repurchase program, indicating potential for increased shareholder returns.
• Employees: Continued growth and acquisitions may lead to more employment opportunities and career development, but integration of new systems and clinics could also bring operational adjustments.
• Customers (Patients): Expansion of clinics and services, including home-care, increases access to physical and occupational therapy services.
• Suppliers: Increased operational scale due to growth and acquisitions may lead to higher demand for supplies and services.
• Creditors: Increased borrowings for acquisitions may raise debt levels, but the company's strong operating income and available credit suggest continued ability to meet financial obligations.

Next Steps

• Continue acquiring multi-clinic outpatient physical therapy practices and home-care physical and speech therapy practices.
• Develop outpatient physical therapy clinics as satellites in existing partnerships.
• Continue acquiring companies that provide industrial injury prevention services.
• Continue implementation of the new financial and human resources system through the end of 2026.
• Evaluate the impact of the 'One Big Beautiful Bill Act' on future tax periods.
• Execute the share repurchase program of up to $25 million through December 31, 2026.
• Pay a quarterly dividend of $0.45 per share on September 12, 2025, to shareholders of record on August 22, 2025.

Key Dates

Recommendation

The company demonstrates exceptional financial performance with robust revenue and net income growth, significantly increasing EPS. Its strategic acquisition model is proving highly effective, expanding its clinic footprint and patient base while successfully navigating industry challenges like Medicare rate reductions. The initiation of a share repurchase program underscores management's confidence in the company's valuation and commitment to returning capital to shareholders. Despite increased debt for growth, liquidity remains strong, positioning the company for continued market leadership and long-term value creation.

Keywords

Physical Therapy, Healthcare Services, Outpatient Rehabilitation, Industrial Injury Prevention, Clinic Acquisitions, SEC Filing, Earnings Report, USPH, Healthcare Industry, Financial Performance, Corporate Growth, Share Repurchase